132 related articles for article (PubMed ID: 29290082)
1. An Overview and Update of Femorofemoral Crossover Bypass Surgery as an Extra-Anatomic Bypass Procedure.
Yuksel A; Cayir MC; Kumtepe G; Velioglu Y; Atli FH; Muduroglu A; Gurbuz O
Thorac Cardiovasc Surg; 2018 Apr; 66(3):266-272. PubMed ID: 29290082
[TBL] [Abstract][Full Text] [Related]
2. Improved patency after axillofemoral bypass for aortoiliac occlusive disease.
Samson RH; Showalter DP; Lepore MR; Nair DG; Dorsay DA; Morales RE
J Vasc Surg; 2018 Nov; 68(5):1430-1437. PubMed ID: 29691098
[TBL] [Abstract][Full Text] [Related]
3. Native Vessel CERAB Re-establishes Aorto-iliac Flow Following Occluded Aortobifemoral Bypass.
Chaudhuri A; Dey R
Eur J Vasc Endovasc Surg; 2018 Mar; 55(3):432. PubMed ID: 29054793
[No Abstract] [Full Text] [Related]
4. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
Rychlik IJ; Davey P; Murphy J; O'Donnell ME
J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
[TBL] [Abstract][Full Text] [Related]
6. A comparative evaluation of femorofemoral crossover bypass and iliofemoral bypass for unilateral iliac artery occlusive disease.
Nazzal MM; Hoballah JJ; Jacobovicz C; Mohan CR; Martinasevic M; Ryan SM; Sharp WJ; Kresowik TF; Corson JD
Angiology; 1998 Apr; 49(4):259-65. PubMed ID: 9555928
[TBL] [Abstract][Full Text] [Related]
7. Extensive Iliofemoral Occlusion After Aortobifemoral Bypass Occlusion: The Potential of Native Artery Recanalization.
Kaichi R; Kawarada O; Yagyu T; Noguchi T; Yasuda S
JACC Cardiovasc Interv; 2018 May; 11(10):1006-1008. PubMed ID: 29454721
[No Abstract] [Full Text] [Related]
8. Endovascular treatment of TransAtlantic Inter-Society Consensus D aortoiliac occlusive disease using unibody bifurcated endografts.
Van Haren RM; Goldstein LJ; Velazquez OC; Karmacharya J; Bornak A
J Vasc Surg; 2017 Feb; 65(2):398-405. PubMed ID: 27765483
[TBL] [Abstract][Full Text] [Related]
9. Iliac Artery Stenting Combined with Ipsilateral Open Femoro-Popliteal Revascularization and Its Effect on Bypass Patency.
Piazza M; Squizzato F; Lepidi S; Menegolo M; Grego F; Antonello M
Ann Vasc Surg; 2017 Oct; 44():282-288. PubMed ID: 28479462
[TBL] [Abstract][Full Text] [Related]
10. Is femorofemoral crossover bypass an option in claudication?
Capoccia L; Riambau V; da Rocha M
Ann Vasc Surg; 2010 Aug; 24(6):828-32. PubMed ID: 20638622
[TBL] [Abstract][Full Text] [Related]
11. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
Assadian A; Eckstein HH;
J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
[TBL] [Abstract][Full Text] [Related]
12. Iliofemoral endarterectomy associated with systematic iliac stent grafting for the treatment of severe iliofemoral occlusive disease.
Maitrias P; Deltombe G; Molin V; Reix T
J Vasc Surg; 2017 Feb; 65(2):406-413. PubMed ID: 27693029
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
[TBL] [Abstract][Full Text] [Related]
14. Jetstream® atherectomy for subacutely or chronically occluded femoro-popliteal prosthetic bypass grafts: a report of three cases.
Obon-Dent M; Hernandez-Vila E
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E529-34. PubMed ID: 22517514
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of PTFE trilaminate graft versus venous graft and composite graft for below-the-knee revascularization.
Mazzaccaro D; De Febis E; Settembrini AM; Tassinari L; Carmo M; Settembrini PG
J Cardiovasc Surg (Torino); 2014 Oct; 55(5):685-91. PubMed ID: 25008059
[TBL] [Abstract][Full Text] [Related]
16. Femorofemoral bypass as an alternative to a direct aortic approach in daily practice: appraisal of its current indications and midterm results.
Rinckenbach S; Guelle N; Lillaz J; Al Sayed M; Ritucci V; Camelot G
Ann Vasc Surg; 2012 Apr; 26(3):359-64. PubMed ID: 22050878
[TBL] [Abstract][Full Text] [Related]
17. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
[TBL] [Abstract][Full Text] [Related]
18. Single-center experience in endovascular treatment for infrainguinal bypass obstructions.
Baumann F; Engelberger RP; Makaloski V; Do DD; Baumgartner I; Diehm N
J Vasc Interv Radiol; 2012 Aug; 23(8):1055-62. PubMed ID: 22840804
[TBL] [Abstract][Full Text] [Related]
19. Crossover femoropopliteal bypass: single graft or double grafts.
Gokalp O; Yurekli I; Yilik L; Bayrak S; Yasa H; Sahin A; Kestelli M; Yetkin U; Gurbuz A
Ann Vasc Surg; 2012 Jul; 26(5):707-14. PubMed ID: 22325924
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
